Trump told Pfizer CEO price hikes hurt his drug plan: source


NEW YORK/WASHINGTON (Reuters) – U.S. President Donald Trump called Pfizer Chief Executive Ian Read on Tuesday to say the company’s July 1 price hikes had complicated the administration’s drug pricing plans, prompting the company to defer its planned increases, according to a source familiar with the matter.

FILE PHOTO: The Pfizer logo is seen at their world headquarters in New York April 28, 2014. REUTERS/Andrew Kelly/File Photo

Pfizer said on Tuesday it was deferring its drug price increases on around 40 drugs for no more than six months after Read’s conversation with Trump.

U.S….



Read More Here

Be the first to comment on "Trump told Pfizer CEO price hikes hurt his drug plan: source"

Leave a comment

Your email address will not be published.


*